← Back to Search

Other

Part 3 for Breast Cancer

Phase 1

Waitlist Available

Research Sponsored by Sun Pharma Advanced Research Company Limited

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up every 8 weeks, for 'time point response (partial response[pr], stable disease[sd], disease progression [dp] or complete response [cr]), through study completion, an average of 1 year.

Awards & highlights

Study Summary

This trial is testing a new drug, SCO-120, on patients with metastatic breast cancer who have failed other treatments. The first part of the trial is to determine the maximum tolerated dose and to assess the drug's safety, tolerability, and preliminary efficacy. The second part will further evaluate the preliminary efficacy of the drug in patients with metastatic breast cancer who have failed other treatments.

Eligible Conditions

Breast Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ every 8 weeks, for 'time point response (partial response[pr], stable disease[sd], disease progression [dp] or complete response [cr]), through study completion, an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~every 8 weeks, for 'time point response (partial response[pr], stable disease[sd], disease progression [dp] or complete response [cr]), through study completion, an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and every 8 weeks, for 'time point response (partial response[pr], stable disease[sd], disease progression [dp] or complete response [cr]), through study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence and severity of adverse events with each dose level

Incidence of dose limiting toxicities at each dose levels (Part 1 only)

Secondary outcome measures

evaluation of AUC (Part 1 and Part 2)

evaluation of Cmax (Part 1 and Part 2)

evaluation of tmax (Part 1 and Part 2)

+1 more

Other outcome measures

pharmacodynamic biomarker

Trial Design

1Treatment groups

Experimental Treatment

Group I: SCO-120Experimental Treatment3 Interventions

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Part 1

2017

Completed Phase 1

~50

Part 2

1999

N/A

~340

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Sun Pharma Advanced Research Company LimitedLead Sponsor

32 Previous Clinical Trials

4,578 Total Patients Enrolled

1 Trials studying Breast Cancer

33 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How secure is Phase 3 for participants?

"There is only a small amount of evidence backing the safety and efficacy of Part 3, so it was rated 1 on our team's scale."

Answered by AI

In what locations have clinicians begun conducting this research endeavor?

"This clinical trial is recruiting participants from Cedars-Sinai Medical Centre, The University of Chicago and Michigan Center of Medical Research among 5 other sites."

Answered by AI

Is this medical study presently seeking participants?

"According to the clinical trials database, this experiment is currently open for recruitment. It was first advertised on May 20th 2022 and its information has been revised as recently as October 29th of the same year."

Answered by AI

How many individuals are participating in this research endeavor?

"Affirmative. Clinical trial records show that this experiment is currently looking for volunteers, with 167 patients being sought from 5 distinct locations. The study was first launched on May 20th 2022 and has been updated most recently as of October 29th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study in Patients With Advanced Breast Cancer

2022. "A Study in Patients With Advanced Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04942054.